Anebulo Pharmaceuticals, Inc. (ANEB) SEC Filings — 2025
13 SEC filings for Anebulo Pharmaceuticals, Inc. (ANEB) in 2025.
Filings
- Anebulo Pharmaceuticals Files 8-K — 8-K · Dec 22, 2025
- Anebulo Narrows Q1 Loss to $2.16M Amid R&D Cuts — 10-Q · Nov 13, 2025
- Anebulo Zero Revenue, Eyes Cannabis Toxicity Treatment Amid Go-Private Plan — 10-K · Sep 29, 2025
- Anebulo Pharmaceuticals Files 8-K — 8-K · Sep 12, 2025
- Anebulo Pharmaceuticals Files 8-K — 8-K · Jul 23, 2025
- Anebulo Pharmaceuticals Files 10-Q for Q3 2025 — 10-Q · May 13, 2025
- Anebulo Pharmaceuticals Files 8-K — 8-K · Apr 15, 2025
- Anebulo Pharmaceuticals Files 8-K — 8-K · Apr 14, 2025
- Anebulo Pharmaceuticals Reports Director/Officer Changes & Shareholder Votes — 8-K · Apr 7, 2025
- Anebulo Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Mar 6, 2025
- Anebulo Pharma Files 8-K: Material Agreement & Delisting Notice — 8-K · Feb 24, 2025
- Anebulo Pharmaceuticals Files Q2 2025 10-Q — 10-Q · Feb 14, 2025
- Anebulo Pharmaceuticals to Acquire Neuro-Bio Ltd. for $10M — 8-K · Feb 12, 2025